GT Biopharma, Inc. (GTBP)
Pharmaceutical Preparations
Latest Price
$0.29
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.25
P/B Ratio
1.17
Institutional Ownership
4.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 451.9K | -- | 1.28% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 294.5K | -- | 0.84% | +275.2K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 225.9K | -- | 0.64% | -- | 2026-03-31 |
| Arax Advisory Partners | 93.6K | -- | 0.27% | -- | 2026-03-31 |
| CITADEL ADVISORS LLC | 66.2K | -- | 0.19% | -14.6K | 2026-03-31 |
| SeaCrest Wealth Management, LLC | 50.0K | -- | 0.14% | -- | 2026-03-31 |
| UBS Group AG | 46.0K | -- | 0.13% | +46.0K | 2026-03-31 |
| LPL Financial LLC | 30.4K | -- | 0.09% | +19.8K | 2026-03-31 |
| Invst, LLC | 23.4K | -- | 0.07% | -- | 2026-03-31 |
| OSAIC HOLDINGS, INC. | 21.0K | -- | 0.06% | +19.0K | 2026-03-31 |